Molecular Pathology of Solid Tumors in Childhood

儿童实体瘤的分子病理学

基本信息

  • 批准号:
    10307004
  • 负责人:
  • 金额:
    $ 24.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

We performed molecular pathological analysis of embryonal tumors such as germ cell tumors, Wilms tumors and Ewing/PNET tumors which are thought to be derived from embryonal tissue during.1, we originally isolated EAT (early gene induced by all trans retinoic acid) gene from embryonal carcinoma cell lines (NCR-G3). Sequencing analysis revealed that EAT possessed BH1 and BH2 domains suggesting a bcl family gene. This gene was shown to have antiapoptotic functions by vitro and in vivo studies. Northern analysis and immunohistochemical studies disclosed that he EAT gene distributed in a variety of fetal and adult tissues including stage of early embryogenesis. EAT gene was shown to exclusively localize in the external and internal membrane of mitochondria by using immunoelectron microscopic procedures. These findings suggested that this gene play an important role in maintenance of early embryogenesis through antiapoptotic functions.2, Wilms tumor are a typical embryonal tumors that is der … More ived from metanephric blastoma and the most common renal tumors in childhood. Novel gene, WT1, has been isolated chromosome11p13 region as a responsible gene in oncogenesis of Wilms tumor. This gene also play an important role in normal nephrogenesis and gonadal developments, especially male genital organs. Denys-Drash syndrome characterized by association of Wilms tumor, early onset and progressive renal failure and urogenital anomalies. Recent studies showed that exonic mutations at zinc finger domains of WT1 is responsible for pathogenesis of this syndrome. We analyzed WT1 mutations in 18 clinically diagnosed "Denys-Drash"(Drash) syndrome cases. 9 cases were typical Drash syndrome. Whereas another cases showed inronic point mutations at the splicing donor site at exon9. These mutations affect alternative splicing. The isoforms retaining three amino acids, KTS, are not produced. Clinical features of the patients with the intronic mutations correlated well with those of Frasier syndrome, characterized by more slowly progressing nephropathy than Denys-Drash syndrome, associated streak gonads and no development of Wilms' tumor. Our results indicate that WT1 isoforms with or without KTS have different functions in tumorigenesis and organogenesis of kidneys and gonads. Less
我们对胚胎,Wilms肿瘤和EWING/PNET肿瘤进行了分子病理分析,而在1期间,我们是从胚胎组织中进行的。我们最初是从胚胎癌细胞系(NCR-癌细胞系(NCR-癌细胞)基因诱导的(所有跨性别视黄度酸)基因(NCR-癌细胞)的早期基因(NCR-- G3如何通过体内分析和免疫组织化学研究来揭示出在早期胚胎发生的多种胎儿组织中,可以揭示出分布的基因通过抗抑制作用的早期胚胎发生在儿童时期中最常见的肾脏肿瘤。 Wilms肿瘤的表征,尿液肿瘤的早期肾脏衰竭和WT1的锌指域是综合征的发病率具有内含子突变的Ients酸是酸综合症SH综合征的Ients,我们的结果具有或没有KTS的带有潜水的Nctions的肿瘤和肾脏和肿瘤的有机化。

项目成果

期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsushita K, Hata J, et al.: "The EAT/mcl-1 gene, an inhibitor of apoptosis, is up-regulated in the early stage of acute myocardial infarction"BBA. 1472. 471-478 (1999)
Matsushita K、Hata J 等人:“EAT/mcl-1 基因是细胞凋亡的抑制剂,在急性心肌梗死的早期阶段上调”BBA。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ando T, Hata J, et al.: "EAT/mcl-1,a Member of the bcl-2 Related Genes, Confers Resistance to Apoptosis Induced by cis-Diamine"Jpn J Cancer Res. 89. 1326-1333 (1998)
Ando T、Hata J 等人:“EAT/mcl-1,bcl-2 相关基因的成员,赋予对顺式二胺诱导的细胞凋亡的抵抗力”Jpn J Cancer Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fukushima,S.: "Augmentation of human leukemic cell invasion by the activation of small GTP-binding protein Rho"Expt Hematol. (in press). (2000)
Fukushima,S.:“通过激活小 GTP 结合蛋白 Rho 增强人类白血病细胞的侵袭”Expt Hematol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada,T.: "Function of 90kDa heat shock pretein in cellular differentiation of human embryonic carcinoma cells"IN Vitro and Developmental Biol,. (in press). (2000)
Yamada,T.:“90kDa 热休克蛋白在人胚胎癌细胞细胞分化中的功能”体外和发育生物学,。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Makino S, Hata J, et al.: "Cardiomyocytes can be generated from marrow stromal cells in vitro"J Clin Invest. 103. 697-705 (1999)
Makino S、Hata J 等人:“心肌细胞可以在体外由骨髓基质细胞产生”J Clin Invest。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HATA Jun-ichi其他文献

HATA Jun-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HATA Jun-ichi', 18)}}的其他基金

Establishment of neuroblastoma regression model and molecular mechanisms
神经母细胞瘤消退模型的建立及分子机制
  • 批准号:
    14570164
  • 财政年份:
    2002
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel humanized-mice and application to regenerative medicine
新型人源化小鼠的研制及其在再生医学中的应用
  • 批准号:
    12357002
  • 财政年份:
    2000
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular and Cell Biological Differentiation Capabilities on Human Germ Cell Tumor Cells
人类生殖细胞肿瘤细胞的分子和细胞生物分化能力
  • 批准号:
    03454174
  • 财政年份:
    1991
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Development of novel therapies for ENL-mutated Wilms tumor
ENL 突变肾母细胞瘤新疗法的开发
  • 批准号:
    22KK0119
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Wilms tumor 1 (Wt1) mutation reveals mechanisms of cell lineage crosstalk in the developing kidney
肾母细胞瘤 1 (Wt1) 突变揭示了发育中肾脏中细胞谱系串扰的机制
  • 批准号:
    10524717
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Wilms tumor 1 (Wt1) mutation reveals mechanisms of cell lineage crosstalk in the developing kidney
肾母细胞瘤 1 (Wt1) 突变揭示了发育中肾脏中细胞谱系串扰的机制
  • 批准号:
    10665776
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Elucidating Oncogenic Mechanisms Underlying Wilms Tumor Using Kidney Organoids
使用肾脏类器官阐明肾母细胞瘤的致癌机制
  • 批准号:
    10324558
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor
WT1 作为间变性肾母细胞瘤的癌基因和治疗靶点
  • 批准号:
    10552546
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了